Survival, classifications, and desmosomal plaque genes in non-small cell lung cancer

International Journal of Medical Sciences

Volumn 10, Issue 9, 2013, Pages 1166-1173

  Boyero, Laura ^a   Sánchez Palencia, Abel ^b   Miranda León, M Teresa ^a   Hernández Escobar, Fernando ^b   Gómez Capilla, Jose Antonio ^a   Fárez Vidal, M Esther ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Adenocarcinoma; Desmosomal plaque; Non small cell lung cancer; Squamous cell carcinoma; Survival

Indexed keywords

CISPLATIN; NAVELBINE;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DESMOSOMAL PLAQUE GENE; FEMALE; GENE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; KRT15 GENE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PKP1 GENE; PREDICTIVE VALUE; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; SURVIVAL TIME; UPREGULATION;

EID: 84880124693     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5747     Document Type: Article

References (22)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics, 2010. CA Cancer J Clin. 2010; 60:277-300.
2. Li Z, Yu Y, Lu J, Luo Q, Wu C, Liao M, Zheng Y, Ai X, Gu L, Lu S. Analysis of the T Descriptors and Other Prognosis Factors in Pathologic Stage I Non-small Cell Lung Cancer in China. J Thorac Oncol. 2009; 4:702-709.
3. Shepherd FA, Crowley J, Van Houtte P, Postmus PE, Carney D, Chansky K, Shaikh Z, Goldstraw P; International Association for the Study of Lung Cancer International Staging Committee and Participating Institutions. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals Regarding the Clinical Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the Tumor, Node, Metastasis Classification for Lung Cancer. J Thorac Oncol. 2007; 2:1067-1077.
4. Deslauriers J, Grégoire J. Clinical and Surgical Staging of Non-Small Cell Lung Cancer. CHEST. 2000; 117:96S-103S.
5. Yoshida J, Nagai K, Asamura H, Goya T, Koshiishi Y, Sohara Y, Eguchi K, Mori M, Nakanishi Y, Tsuchiya R, Miyaoka E; Japanese Joint Committee for Lung Cancer Registration. Visceral Pleura Invasion Impact on Non-small Cell Lung Cancer Patient Survival. Its Implications for the Forthcoming TNM Staging Based on a Large-Scale Nation-Wide Database. J Thorac Oncol. 2009; 4:959-963.
6. Välk K, Vooder T, Kolde R, Reintam MA, Petzold C, Vilo J, Metspalu A. Gene expression profiles of non-small cell lung cancer: survival prediction and new biomarkers. Oncology. 2010; 79:283-292.
7. Zhu CQ, Ding K, Strumpf D, Weir BA, Meyerson M, Pennell N, Thomas RK, Naoki K, Ladd-Acosta C, Liu N, Pintilie M, Der S, Seymour L, Ju-risica I, Shepherd FA, Tsao MS. Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. J Clin Oncol. 2010; 28:4417-4424.
8. Kadara H, Fujimoto J, Men T, Ye X, Lotan D, Lee JS, Lotan R. A Gprc5a tumor suppressor loss of expression signature is conserved, prevalent, and associated with survival in human lung adenocarcinomas. Neoplasia. 2010; 12:499-505.
9. Sanchez-Palencia A, Gomez-Morales M, Gomez-Capilla JA, Pedraza V, Boyero L, Rosell R, Fárez-Vidal ME. Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer. Int J Cancer. 2010; 129(2):355-364.
10. Narayana N, Gist J, Smith T, Tylka D, Trogdon G, Wahl JK. Desmosomal component expression in normal, dysplastic, and oral squamous cell carcinoma. Dermatol Res Pract. 2010; 2010:649731.
11. Badock V, Steinhusen U, Bommert K, Wittmann-Liebold B, Otto A. Apoptosis-induced cleavage of keratin 15 and keratin 17 in a human breast epithelial cell line. Cell Death Differ. 2001; 8:308-315.
12. Yoshida S, Shimmura S, Kawakita T, Miyashita H, Den S, Shimazaki J, Tsubota K. Cytokeratin 15 can be used to identify the limbal phenotype in normal and diseased ocular surfaces. Invest Ophthalmol Vis Sci. 2006; 47:4780-4786.
13. Rena O, Massera F, Robustellini M, Papalia E, Delfanti R, Lisi E, Pi-rondini E, Turello D, Casadio C. Use of the Proposals of the International Association for the Study of Lung Cancer in the Forthcoming Edition of Lung Cancer Staging System to Predict Long-Term Prognosis of Operated Patients. Cancer J. 2010; 16:176-181.
14. Riquet M, Manac'h D, Le Pimpec Barthes F, Dujon A, Debrosse D, De-besse B. Prognostic value of T and N in non small cell lung cancer three centimeters or less in diameter. Eur J Cardiothorac Surg. 1997; 11:440-444.
15. Konaka C, Hirano T, Kato H, Furuse K, Takada M, Saito Y, Monden Y, Matsui E, Watanabe Y. Comparison of endoscopic features of early-stage squamous cell lung cancer and histological findings. Br J Cancer. 1999; 80:1435-1439.
16. Chen C, Zheng H, Gao W, Zhou Y, Jiang S, Suen H. Prognosis and staging of superficial endobronchial lung cancer: the impact of invasion depth, tumor diameter, and coexistent pneumonitis or atelectasis. Chin Med J. 2010; 123: 1505-1509.
17. Travis D, Brambilla E, Müller-Hermelink HK, Harris CC. WHO Classification; Tumors of the lung, pleura, thymus and heart. Albany, NY: WHO Publication Center. 2004.
18. Cooke DT, Nguyen DV, Yang Y, Chen SL, Yu C, Calhoun RF. Survival comparison of adenosquamous, squamous cell, and adenocarcinoma of the lung after lobectomy. Ann Thorac Surg. 2010; 90:943-948.
19. Carrasco JL, Jover L. Estimating the generalized concordance correlation coefficient through variance components. Biometrics. 2003; 59:849-858.
20. Furukawa C, Daigo Y, Ishikawa N, Kato T, Ito T, Tsuchiya E, Sone S, Nakamura Y. Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. Cancer Res. 2005; 65:7102-7110.
21. Shi I, Hashemi Sadraei N, Duan ZH, Shi T. Aberrant signaling pathways in squamous cell lung carcinoma. Cancer Inform. 2011; 10:273-285.
22. Wieskopf B, Demangeat C, Purohit A, Stenger R, Gries P, Kreisman H, Quoix E. Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. CHEST. 1995; 108:163-169.